Edaravone inhibits apoptosis caused by ischemia/ reperfusion injury in a porcine hepatectomy model

World Journal of Gastroenterology

Volumn 18, Issue 27, 2012, Pages 3520-3526

  Shimoda, Mitsugi ^a   Iwasaki, Yoshimi ^a   Okada, Toshie ^a   Kubota, Keiichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Edaravone; Ischemia reperfusion injury; Liver resection; Toll like receptor 4; Transforming growth factor

Indexed keywords

APOPTOSIS INHIBITOR; MESSENGER RNA; NORPHENAZONE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION PROFILING; HEMIHEPATECTOMY; HEMODYNAMICS; HISTOPATHOLOGY; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER ISCHEMIA; LIVER PROTECTION; LIVER REGENERATION; LIVER WEIGHT; MALE; NICK END LABELING; NONHUMAN; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

EID: 84864310461     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i27.3520     Document Type: Article

References (33)

1. Yamawaki M, Sasaki N, Shimoyama M, Miake J, Ogino K, Igawa O, Tajima F, Shigemasa C, Hisatome I. Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes. Br J Pharmacol 2004; 142: 618-626.
2. Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, Iwasaki Y. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 2004; 1029: 200-206.
3. Hiranuma S, Ito K, Noda Y, Ozasa H, Koike Y, Horikawa S. Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats. J Gastroenterol Hepatol 2007; 22: 2167-2172.
4. Pringle JH. V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma. Ann Surg 1908; 48: 541-549.
5. Childs CB, Proper JA, Tucker RF, Moses HL. Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci USA 1982; 79: 5312-5316.
6. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995; 96: 447-455.
7. Russell WE, Coffey RJ, Ouellette AJ, Moses HL. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988; 85: 5126-5130.
8. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335.
9. Watanabe T, Yuki S, Egawa M, Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994; 268: 1597-1604.
10. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375.
11. Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987; 164: 155-158.
12. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162.
13. Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 2003; 90: 17-22.
14. Hanazaki K, Kajikawa S, Fujimori Y, Nakata S, Shimozawa N, Koide N, Adachi W, Amano J. Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma. Hepatogastroenterology 2000; 47: 461-464.
15. Uchinami M, Muraoka R, Horiuchi T, Tabo T, Kimura N, Naito Y, Yoshikawa T. Effect of intermittent hepatic pedicle clamping on free radical generation in the rat iver. Surgery 1998; 124: 49-56.
16. Horiuchi T, Muraoka R, Tabo T, Uchinami M, Kimura N, Tanigawa N. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch Surg 1995; 130: 754-758.
17. Shimoda M, Iwasaki Y, Okada T, Sawada T, Kubota K. Protective effect of Sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle method. Eur J Pharmacol 2008; 587: 248-252.
18. Shimoda M, Sawada T, Iwasaki Y, Mori S, Kijima H, Okada T, Kubota K. Erythropoietin strongly protects the liver from ischemia-reperfusion injury in a pig model. Hepatogastroenterology 2009; 56: 470-475.
19. Kato M, Sawada T, Kita J, Shimoda M, Kubota K. Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver. World J Gastroenterol 2010; 16: 4838-4845.
20. Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637-647.
21. López-Neblina F, Toledo-Pereyra LH. Anti-ischemic effect of selectin blocker through modulation of tumor necrosis factor-alpha and interleukin-10. J Surg Res 2007; 138: 275-283.
22. Clavien PA, Harvey PR, Sanabria JR, Cywes R, Levy GA, Strasberg SM. Lymphocyte adherence in the reperfused rat liver: mechanisms and effects. Hepatology 1993; 17: 131-142.
23. Tsuchihashi S, Fondevila C, Shaw GD, Lorenz M, Marquette K, Benard S, Shen XD, Ke B, Busuttil RW, KupiecWeglinski JW. Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: protection from ischemia-reperfusion injury in liver transplantation. J Immunol 2006; 176: 616-624.
24. Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K. Pharmacological Properties of Magnolol and Hõnokiol Extracted from Magnolia officinalis: Central Depressant Effects. Planta Med 1983; 49: 103-108.
25. Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito KI. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1997; 281: 921-927.
26. Wu TW, Zeng LH, Wu J, Fung KP. Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. Life Sci 2002; 71: 2249-2255.
27. Okatani Y, Wakatsuki A, Enzan H, Miyahara Y. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver. Eur J Pharmacol 2003; 465: 163-170.
28. Kono H, Asakawa M, Fujii H, Maki A, Amemiya H, Yamamoto M, Matsuda M, Matsumoto Y. Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin. J Pharmacol Exp Ther 2003; 307: 74-82.
29. Nakamura A, Akamatsu Y, Miyagi S, Fukumori T, Sekiguchi S, Satomi S. A free radical scavenger, edaravone, prevents ischemia-reperfusion injury in liver grafts from nonheart-beating donors. Transplant Proc 2008; 40: 2171-2174.
30. Ninomiya M, Shimada M, Harada N, Shiotani S, Hiroshige S, Soejima Y, Suehiro T, Sugimachi K. Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. Transplantation 2002; 74: 1470-1472.
31. Ferré N, Clària J. New insights into the regulation of liver inflammation and oxidative stress. Mini Rev Med Chem 2006; 6: 1321-1330.
32. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
33. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201: 1135-1143.